We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · November 23, 2021

Preventing Symptomatic Gallstone Disease After Bariatric Surgery With Ursodeoxycholic Acid

The Lancet Gastroenterology & Hepatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Gastroenterology & Hepatology
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial
Lancet Gastroenterol Hepatol 2021 Oct 26;[EPub Ahead of Print], S Haal, MSS Guman, TCC Boerlage, YIZ Acherman, LM de Brauw, S Bruin, SMM de Castro, JE van Hooft, AWJM van de Laar, DE Moes, M Schouten, R Schouten, EJ van Soest, RN van Veen, CEE de Vries, P Fockens, MGW Dijkgraaf, VEA Gerdes, RP Voermans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading